Clinical Trial Details

Trial ID: L0647
Source ID: IRCT201012084010N4
Associated Drug: Synbiotics
Title: The effects of synbiotics supplement on lipid profile, liver enzymes, inflammatory factors and hepatic fibrosis in patients with Nonalcoholic Steatohepatitis
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic steatohepatitis (NASH). <br>Nonalcoholic steatohepatitis (NASH);Nonalcoholic steatohepatitis (NASH)
Interventions: Intervention 1: intervention: 2 protexin capsules for 7 months. Intervention 2: control: 2 placebo capsule (Maltodexterin) for 7 months.;Treatment - Drugs;Placebo;intervention: 2 protexin capsules for 7 months;control: 2 placebo capsule (Maltodexterin) fo
Outcome Measures: ALT, AST, GGT. Timepoint: at the beginning and at the last. Method of measurement: Biochemistry.;Hs-CRP, TNF-a. Timepoint: at the beginning and at the last. Method of measurement: ELISA & Nephlometer.;Liver fibrosis. Timepoint: at the beginning and at the last. Method of measurement: Fibroscan.;FBS. Timepoint: at the beginning and at the last. Method of measurement: Biochemistry.;Cholestrol, TG, LDL-c, HDL-c. Timepoint: at the beginning and at the last. Method of measurement: Biochemistry.Weight and BMI. Timepoint: at weeks: 0, 14, 28. Method of measurement: Weight will be measured by Secca scale , BMI by formula.;Waist circumference, hip circumfereance. Timepoint: at weeks: 0, 14, 28. Method of measurement: non stretch meter.;Insulin. Timepoint: at weeks: 0, 14, 28. Method of measurement: ELISA.;Insulin resistance. Timepoint: at weeks: 0, 28. Method of measurement: formula.
Sponsor/Collaborators: National Nutrition and Food Technology Research Institute (NNFTRI)
Gender: All
Age: 18 years70 years
Phases: Phase 2/Phase 3
Enrollment: 50
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 30/11/2012
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/4186